SBT 589
Alternative Names: SBT-589Latest Information Update: 02 Apr 2024
At a glance
- Originator Stealth BioTherapeutics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Friedreich's ataxia